Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Ileal Diseases D007077 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Contracture D003286 3 associated lipids
Toxemia D014115 3 associated lipids
Bronchial Diseases D001982 3 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Burns, Inhalation D002059 4 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Brain Injuries D001930 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Chomyszyn-Gajewska M [Evaluation of chosen salivary periodontal disease markers]. 2010 Prz. Lek. pmid:20687387
Thiele T et al. [Heparin-induced thrombocytopenia]. 2010 Internist (Berl) pmid:20694716
Kordan W et al. Effect of platelet activating factor (PAF) supplementation in semen extender on viability and ATP content of cryopreserved canine spermatozoa. 2010 Pol J Vet Sci pmid:21370733
Lin S et al. Abietane and C20-norabietane diterpenes from the stem bark of Fraxinus sieboldiana and their biological activities. 2010 J. Nat. Prod. pmid:20961093
He J et al. The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF). 2010 Curr. Eye Res. pmid:20961214
Rechka A et al. Identification of VEGF receptor-2 tyrosine phosphorylation sites involved in VEGF-mediated endothelial platelet-activating factor synthesis. 2010 Can. J. Physiol. Pharmacol. pmid:20962896
Soliman A et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. 2010 PLoS ONE pmid:20976181
Garcia CC et al. Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. 2010 PLoS Pathog. pmid:21079759
de Souza Carmo EV et al. Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages. 2010 PLoS ONE pmid:21082032
Zhao D et al. PAF exerts a direct apoptotic effect on the rat H9c2 cardiomyocytes in Ca2+-dependent manner. 2010 Int. J. Cardiol. pmid:19237210
Nandy D et al. Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes. 2010 J. Cell. Mol. Med. pmid:19754670
Borthakur A et al. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. 2010 Inflamm. Bowel Dis. pmid:19714753
Fité R and Borja J Rupatadine and heart rhythm disturbances. 2010 Clin. Pharmacol. Ther. pmid:19727070
Kida T et al. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. 2010 Exp. Eye Res. pmid:20412793
Lorrain DS et al. Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation. 2010 Eur. J. Pharmacol. pmid:20519143
Salmon MD and Ahluwalia J Discrimination between receptor- and store-operated Ca(2+) influx in human neutrophils. 2010 Cell. Immunol. pmid:20716450
Corl CM et al. Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge. 2010 Vet. Immunol. Immunopathol. pmid:20359754
Shi C et al. H2O2 and PAF mediate Abeta1-42-induced Ca2+ dyshomeostasis that is blocked by EGb761. 2010 Neurochem. Int. pmid:20362023
Coy B ED et al. The first diastereoselective synthesis of cinerins A-C, PAF-antagonistic macrophyllin-type bicyclo[3.2.1]octane neolignans, using a novel Pd-catalysed oxyarylation. 2010 Org. Biomol. Chem. pmid:20401372
Ritter JM Novel targets and regulatory ordeal by QT interval. 2010 Br J Clin Pharmacol pmid:20406216
Donado E et al. No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. 2010 Br J Clin Pharmacol pmid:20406224
Saad MM et al. Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils. 2010 Can J Anaesth pmid:19882198
Chen H et al. Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease. 2010 Clin Oral Investig pmid:19826843
Sreevidya CS et al. Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. 2010 J. Invest. Dermatol. pmid:19829299
Lautenschläger I et al. A model of the isolated perfused rat small intestine. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19910525
Yang Y et al. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase. 2010 Eur. Respir. J. pmid:19926744
Cureton EL et al. Endothelin 1 and prostacyclin attenuate increases in hydraulic permeability caused by platelet-activating factor in rats. 2010 Shock pmid:19940814
Coppo R et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. 2010 Kidney Int. pmid:20016469
Xu Z et al. Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor. 2010 Mol. Ther. pmid:19953082
Ma J et al. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19959817
Hasegawa S et al. Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. 2010 PLoS ONE pmid:20454616
Yang L et al. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. 2010 J. Biol. Chem. pmid:20460374
Esquenazi S and Bazan HE Role of platelet-activating factor in cell death signaling in the cornea: A review. 2010 Mol. Neurobiol. pmid:20431963
Iyú D et al. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. 2010 Platelets pmid:20433310
Adamson RH et al. Sphingosine-1-phosphate modulation of basal permeability and acute inflammatory responses in rat venular microvessels. 2010 Cardiovasc. Res. pmid:20542878
Liu SH et al. Protection of carbon monoxide intraperitoneal administration from rat intestine injury induced by lipopolysaccharide. 2010 Chin. Med. J. pmid:20497711
Kuebler WM et al. Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. 2010 Cell. Physiol. Biochem. pmid:20502002
Wang L et al. Three new compounds from Morus nigra L. 2010 J Asian Nat Prod Res pmid:20552479
Lu J et al. Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. 2010 Pediatr. Res. pmid:20531249
Kim DD et al. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo. 2010 Microcirculation pmid:20163539
Yost CC et al. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. 2010 Biochimie pmid:20167241
Sharif NA and Wiernas TK Platelet-activating factor-induced intracellular signaling and release of cytokines and prostaglandin E2 in immortalized human corneal epithelial cells. 2010 J Ocul Pharmacol Ther pmid:20187806
Metz M et al. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. 2010 Ann. Allergy Asthma Immunol. pmid:20143651
Xiping Z et al. Effects of dexamethasone and Salvia miltiorrhizae on the small intestine and immune organs of rats with severe acute pancreatitis. 2010 Inflammation pmid:20127399
Incorvaia C et al. Anaphylaxis: an update on its understanding and management. 2010 Recent Pat Inflamm Allergy Drug Discov pmid:20100165
Moriguchi S et al. Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region. 2010 Neuroscience pmid:20074623
Zhou X and He P Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules. 2010 Cardiovasc. Res. pmid:20080986
Kenchegowda S and Bazan HE Significance of lipid mediators in corneal injury and repair. 2010 J. Lipid Res. pmid:19965607
Jørgensen KM et al. Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2. 2010 Arch. Dermatol. Res. pmid:20041255
Coy Barrera ED and Cuca Suárez LE In vitro inhibitory activities of Lauraceae aporphine alkaloids. 2010 Nat Prod Commun pmid:20420312
Dyer KD et al. Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor. 2010 J. Immunol. pmid:20421642
Bate C et al. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation. 2010 J. Biol. Chem. pmid:20427265
Grassi G et al. Exogenous platelet-activating factor improves the motility of human spermatozoa evaluated with C.A.S.A.: optimal concentration and incubation time. 2010 J. Endocrinol. Invest. pmid:20220291
Binder U et al. The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans. 2010 Mol. Microbiol. pmid:19889092
Shindou H [Discovery and characterization of novel lysophospholipid acyltransferases]. 2010 Seikagaku pmid:21348263
Peng SY et al. [Effect of ginkgolide B on the production of NO, IL-6 and RANTES from astrocytes]. 2010 Yao Xue Xue Bao pmid:21351565
Ciprandi G and Cirillo I Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study. 2010 Apr-Jun J. Biol. Regul. Homeost. Agents pmid:20487631
Ploppa A et al. Local anesthetic effects on human neutrophil priming and activation. 2010 Jan-Feb Reg Anesth Pain Med pmid:20048657
Michelotto PV et al. Platelet-activating factor and evidence of oxidative stress in the bronchoalveolar fluid of Thoroughbred colts during race training. 2010 Mar-Apr J. Vet. Intern. Med. pmid:20102491
Ha SW and Lee CS Differential effect of platelet activating factor on 1-methyl-4-phenylpyridinium-induced cell death through regulation of apoptosis-related protein activation. 2010 May-Jun Neurochem. Int. pmid:20304020
Lenshof A and Laurell T Emerging clinical applications of microchip-based acoustophoresis. 2011 J Lab Autom pmid:22093301
Zhou X and He P Temporal and spatial correlation of platelet-activating factor-induced increases in endothelial [Ca²⁺]i, nitric oxide, and gap formation in intact venules. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21873500
Alarcón P et al. D-lactic acid interferes with the effects of platelet activating factor on bovine neutrophils. 2011 Vet. Immunol. Immunopathol. pmid:21816488
Machado GB et al. Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. 2011 Respir. Res. pmid:21819560
Drolet AM et al. Platelet-activating factor induces Th17 cell differentiation. 2011 Mediators Inflamm. pmid:22013287
Janakiram NB et al. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. 2011 Cancer Metastasis Rev. pmid:22015691
Verouti SN et al. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects. 2011 Atherosclerosis pmid:21920519
Yu Y et al. Homosecoiridoids from the flower buds of Lonicera japonica. 2011 J. Nat. Prod. pmid:21942812
Ajiro Y et al. Platelet-activating factor stimulates sodium-hydrogen exchange in ventricular myocytes. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21949111
Ma J et al. ATP: a mediator for HCl-induced TRPV1 activation in esophageal mucosa. 2011 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:21960521
Bragado MJ et al. Platelet-activating factor in Iberian pig spermatozoa: receptor expression and role as enhancer of the calcium-induced acrosome reaction. 2011 Reprod. Domest. Anim. pmid:22023717
Rastogi P et al. Urothelial cell platelet-activating factor production mediated by calcium-independent phospholipase A2γ. 2011 Urology pmid:21094990
Uriarte SM et al. Granule exocytosis contributes to priming and activation of the human neutrophil respiratory burst. 2011 J. Immunol. pmid:21642540
Frelinger AL et al. Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44. 2011 Thromb. Haemost. pmid:21713327
Byrne SN et al. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. 2011 Am. J. Pathol. pmid:21703403
Semini G et al. Impact of alkylphospholipids on the gene expression profile of HaCaT cells. 2011 Pharmacogenet. Genomics pmid:21681147
Khan BQ and Kemp SF Pathophysiology of anaphylaxis. 2011 Curr Opin Allergy Clin Immunol pmid:21659865
Parrill AL et al. Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7. 2011 BMC Biochem. pmid:22177013
Lacy P et al. Agonist activation of f-actin-mediated eosinophil shape change and mediator release is dependent on Rac2. 2011 Int. Arch. Allergy Immunol. pmid:21576984
Howard KM et al. Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways. 2011 Inflamm. Res. pmid:21432021
Jönsson F et al. Mouse and human neutrophils induce anaphylaxis. 2011 J. Clin. Invest. pmid:21436586
Côrte-Real R et al. The activity of platelet activating factor-acetyl hydrolase (PAF-AH) in the salivary glands of Rhodnius prolixus. 2011 J. Insect Physiol. pmid:21439293
Li XJ et al. [Expression of platelet-activating factor in necrotizing enterocolitis and its clinical significance]. 2011 Zhonghua Bing Li Xue Za Zhi pmid:21426810
Leistad L et al. Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage. 2011 Scand. J. Rheumatol. pmid:21417548
Xu LF et al. Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. 2011 Arch. Pharm. Res. pmid:21380808
Orlando RC et al. Esophageal disease: updated information on inflammation. 2011 Ann. N. Y. Acad. Sci. pmid:21950828
Fang W et al. Platelet activating factor induces blood brain barrier permeability alteration in vitro. 2011 J. Neuroimmunol. pmid:20870297
Fragel-Madeira L et al. Platelet activating factor blocks interkinetic nuclear migration in retinal progenitors through an arrest of the cell cycle at the S/G2 transition. 2011 PLoS ONE pmid:21298035
Garland RC et al. Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury. 2011 FASEB J. pmid:21257713
Mushtaq N et al. Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. 2011 J. Allergy Clin. Immunol. pmid:21247619
Singh TP et al. Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice. 2011 Am. J. Pathol. pmid:21281802
Metz M and Maurer M Rupatadine for the treatment of allergic rhinitis and urticaria. 2011 Expert Rev Clin Immunol pmid:21162645
Cureton EL et al. Endothelin-1 attenuates increases in hydraulic conductivity due to platelet-activating factor via prostacyclin release. 2011 J. Appl. Physiol. pmid:21183623
Liu J et al. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase. 2011 Circ. Res. pmid:21183738
Soares PM et al. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. 2011 Cancer Chemother. Pharmacol. pmid:21153821
Zimmermann LT et al. Effects of platelet-activating factor on the interaction of Trypanosoma cruzi with Rhodnius prolixus. 2011 Parasitol. Res. pmid:21161276
Musto AE and Samii M Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. 2011 Epilepsia pmid:21204830
Lowry P 1-O-alkenyl-sn-glyceryl-3-phosphorylcholine may be a novel posttranslational modification used by the placenta. 2011 Biopolymers pmid:20564011
Kennedy MA et al. Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factor. 2011 PLoS Genet. pmid:21347278
Kim HA et al. Mechanisms of platelet-activating factor-induced enhancement of VEGF expression. 2011 Cell. Physiol. Biochem. pmid:21325822